NEW YORK, Jan. 15, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nu Skin Enterprises, Inc. ("Nu Skin" or the "Company") (NYSE: NUS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or......
More...







